Pharmerging Market Size Is Anticipated To Reach USD 2.08 Trillion By 2030


 San Francisco, 19 Sep 2024: The Report Pharmerging Market Size, Share & Trends Analysis Report By Product (Pharmaceutical, Healthcare), By Economy (Tier-1, Tier-2), By Indication (Lifestyle Disease, Infectious Disease), By Region, And Segment Forecasts, 2024 - 2030

The global pharmerging market size is expected to reach USD 2.08 trillion in 2030 and is projected to grow at a CAGR of 2.6% from 2024 to 2030. This market is expected to grow due to the increasing geriatric population, increasing disease burden of chronic disorders, and increasing healthcare expenditure. 

According to the United Nations (UN), the number of people above the age of 60 years is estimated to be 901 million in 2015. The increasing geriatric population boosts the demand for better treatment options for chronic diseases such as hyperlipidemia, hypertension, cancer, dementia, congestive heart failure. According to a study conducted by Deloitte in 2011, the geriatric population accounts for almost 23.0-40.0% of the prescription drug market, and 40.0-50.0% of the OTC drug market. Another driving factor for the pharmerging market is increasing healthcare expenditure.

The increasing disease burden of chronic diseases in developing countries is boosting growth in the market. According to the Global Health Observatory data, in 2015, 70.0% of the deaths were due to non-communicable diseases (NCD). The major NCDs are cardiovascular diseases (CVD) which caused 45.0% of all NCD deaths, cancer which caused 22.0% of all NCD deaths and chronic obstructive pulmonary disease (COPD) which causes 10.0% of all NCD deaths, and diabetes which caused 4.0% of all NCD deaths.

Access Research Report of Pharmerging Market @ https://www.grandviewresearch.com/industry-analysis/pharmerging-market

Pharmerging Market Report Highlights

  • The pharmaceutical product segment dominated the market and accounted for the largest revenue share of 85.0% in 2023.
  • The tier-1 economy led the market, accounting for the largest market share at 60.5% in 2023.
  • The key strategic initiatives include new product launches, acquisitions and mergers, and collaborations.

Pharmerging Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 1.78 trillion

Revenue forecast in 2030

USD 2.08 trillion

Growth Rate

CAGR of 2.6% from 2024 to 2030

Base year for estimation

2023

Historical data

2018 - 2022

Forecast period

2024 - 2030

List of Key Players in Pharmerging Market

  • Sanofi
  • Pfizer Inc.
  • AstraZeneca
  • GlaxoSmithKline
  • Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Eli Lilly and Company
  • Medtronic
  • Abbott
  • Johnson and Johnson

Access Press Release of Pharmerging Market @ https://www.grandviewresearch.com/press-release/global-pharmerging-market

About Grand View Research

Grand View Research is an India & U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services.

For More Information: https://www.grandviewresearch.com/horizon

Comments

Post a Comment

Popular posts from this blog

Europe Reusable Water Bottle Market Size Is Anticipated To Reach USD 2.36 Billion By 2028

 Get To Know : https://tinyurl.com/ya8dw47e Rising awareness regarding plastic pollution levels across the region is influencing consumers to disregard bottled water, thereby driving the market for the reusable water bottle. In addition, the adoption of a healthier lifestyle among consumers to keep themselves hydrated is expected to boost the sales of the product in the forecast period.
Read more

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more